BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12625408)

  • 1. Adult growth hormone deficiency in Japan: results of investigation by questionnaire.
    Kaji H; Sakurai T; Iguchi G; Murata M; Kishimoto M; Yoshioka S; Iida K; Okimura Y; Chihara K
    Endocr J; 2002 Dec; 49(6):597-604. PubMed ID: 12625408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender has to be taken into account in diagnosing adult growth hormone deficiency by the GHRH plus arginine test.
    Markkanen HM; Pekkarinen T; Hämäläinen E; Välimäki MJ; Alfthan H; Stenman UH
    Growth Horm IGF Res; 2017 Aug; 35():52-56. PubMed ID: 28755537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Long-Term Growth Hormone Replacement Therapy on Metabolic and Cardiovascular Parameters in Adult Growth Hormone Deficiency: Comparison Between Adult and Elderly Patients.
    Scarano E; Riccio E; Somma T; Arianna R; Romano F; Di Benedetto E; de Alteriis G; Colao A; Di Somma C
    Front Endocrinol (Lausanne); 2021; 12():635983. PubMed ID: 33716985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult growth hormone deficiency. Metabolic alterations and evaluation of different risk groups.
    Fideleff HL; Chervin A; Giaccio A; Sobrado P; Barmat R; Boquete H;
    Medicina (B Aires); 2004; 64(1):13-9. PubMed ID: 15034951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD].
    Arita K; Hirano H; Tominaga A; Kurisu K
    Brain Nerve; 2008 Dec; 60(12):1445-54. PubMed ID: 19110756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
    Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report.
    Bohdanowicz-Pawlak A; Szymczak J; Bladowska J; Bednarek-Tupikowska G; Bidzińska B; Milewicz A
    Med Sci Monit; 2006 Feb; 12(2):CR75-80. PubMed ID: 16449951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.
    Verhelst J; Mattsson AF; Luger A; Thunander M; Góth MI; Koltowska-Häggström M; Abs R
    Eur J Endocrinol; 2011 Dec; 165(6):881-9. PubMed ID: 21969523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood-Onset Adult Growth Hormone Deficiency: Clinical, Hormonal, and Radiological Assessment in a Single Center in China.
    Yang H; Zhu H; Yan K; Pan H
    Horm Res Paediatr; 2017; 88(2):155-159. PubMed ID: 28719905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Accumulation Product: a Simple and Accurate Index for Predicting Metabolic Syndrome in Patients with Adult Growth Hormone Deficiency.
    Chan L; Xue H; Xiaoya Z; Jiajia X; Wei R; Linman L; Qing L; Lan L
    Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):220-4. PubMed ID: 27123781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socio-economic impact and health status. Collaborative ODA (Observational GH Deficiency in Adults) Group.
    Sanmartí A; Lucas A; Hawkins F; Webb SM; Ulied A
    Eur J Endocrinol; 1999 Nov; 141(5):481-9. PubMed ID: 10576764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macimorelin as a Diagnostic Test for Adult GH Deficiency.
    Garcia JM; Biller BMK; Korbonits M; Popovic V; Luger A; Strasburger CJ; Chanson P; Medic-Stojanoska M; Schopohl J; Zakrzewska A; Pekic S; Bolanowski M; Swerdloff R; Wang C; Blevins T; Marcelli M; Ammer N; Sachse R; Yuen KCJ
    J Clin Endocrinol Metab; 2018 Aug; 103(8):3083-3093. PubMed ID: 29860473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of the Growth hormone deficiency and Efficacy of Treatment (GET) score and non-interventional proof of concept study.
    Kann PH; Bergmann S; Bidlingmaier M; Dimopoulou C; Pedersen BT; Stalla GK; Weber MM; Meckes-Ferber S
    BMC Endocr Disord; 2018 Feb; 18(1):10. PubMed ID: 29433573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.
    Corneli G; Di Somma C; Baldelli R; Rovere S; Gasco V; Croce CG; Grottoli S; Maccario M; Colao A; Lombardi G; Ghigo E; Camanni F; Aimaretti G
    Eur J Endocrinol; 2005 Aug; 153(2):257-64. PubMed ID: 16061832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners.
    Davies JS; Obuobie K; Smith J; Rees DA; Furlong A; Davies N; Evans LM; Scanlon MF
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):295-303. PubMed ID: 10718827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults?
    Diri H; Karaca Z; Simsek Y; Tanriverdi F; Unluhizarci K; Selcuklu A; Kelestimur F
    Pituitary; 2015 Dec; 18(6):884-92. PubMed ID: 26129876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
    Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
    Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.